Product NDC: | 0023-9321 |
Proprietary Name: | ALPHAGAN P |
Non Proprietary Name: | brimonidine tartrate |
Active Ingredient(s): | 1 mg/mL & nbsp; brimonidine tartrate |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION/ DROPS |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0023-9321 |
Labeler Name: | Allergan, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021770 |
Marketing Category: | NDA |
Start Marketing Date: | 20060125 |
Package NDC: | 0023-9321-15 |
Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (0023-9321-15) > 15 mL in 1 BOTTLE, DROPPER |
NDC Code | 0023-9321-15 |
Proprietary Name | ALPHAGAN P |
Package Description | 1 BOTTLE, DROPPER in 1 CARTON (0023-9321-15) > 15 mL in 1 BOTTLE, DROPPER |
Product NDC | 0023-9321 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | brimonidine tartrate |
Dosage Form Name | SOLUTION/ DROPS |
Route Name | OPHTHALMIC |
Start Marketing Date | 20060125 |
Marketing Category Name | NDA |
Labeler Name | Allergan, Inc. |
Substance Name | BRIMONIDINE TARTRATE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |